Drug class
Calcitonin Gene-related Peptide Receptor Antagonist
5 drugs the FDA files under Calcitonin Gene-related Peptide Receptor Antagonist, and that we can price. Drugs in one class are not interchangeable — they share a mechanism, not a dose or a set of side effects — but the price gap between them is often large, and it is a reasonable thing to raise with a prescriber.
- atogepant 10 MG Oral Tablet [Qulipta]Calcitonin Gene-related Peptide Receptor Antagonist
- atogepant 30 MG Oral Tablet [Qulipta]Calcitonin Gene-related Peptide Receptor Antagonist
- atogepant 60 MG Oral Tablet [Qulipta]Calcitonin Gene-related Peptide Receptor Antagonist
- ubrogepant 100 MG Oral Tablet [Ubrelvy]Calcitonin Gene-related Peptide Receptor Antagonist
- ubrogepant 50 MG Oral Tablet [Ubrelvy]Calcitonin Gene-related Peptide Receptor Antagonist